Antigenics Inc.

Antigenics Provides Details On GlaxoSmithKline's Pivotal Malaria Vaccine Trial With QS-21 Adjuvant.
Pediatrics Week; 11/21/2009; 1069 words; Antigenics, Inc. (NASDAQ: AGEN) today indicated...vaccine clinical trial, containing Antigenics' QS-21 Stimulon[R] adjuvant...Therapy, Treatment, Vaccination, Antigenics Inc. This article was prepared by Pediatrics...

Antigenics Reports Third Quarter 2009 Financial Results.(Financial report)
Cancer Weekly; 11/10/2009; 1258 words; Antigenics Inc. (NASDAQ: AGEN) reported its results...determine the best path forward (see also Antigenics Inc.). The Brain Tumor Research Center...sustain operations into 2011. Keywords: Antigenics Inc., Health, Biotechnology, Oncology...

FORM 8-K: ANTIGENICS ANNOUNCES REGULATION FD DISCLOSURE
US Fed News Service, Including US State News; 11/6/2009; 448 words; WASHINGTON, Nov. 4 -- ANTIGENICS INC., Lexington, Mass., files...as specified in its charter is ANTIGENICS INC. State of Incorporation: DELAWARE...Regulation FD Disclosure On Nov. 4, Antigenics Inc. announced that GlaxoSmithKline...

Antigenics' Leukemia Vaccine AG-858 Enters Phase II Study.
BIOWORLD Today; 11/4/2009; 994 words; National Editor Antigenics Inc. said it may be able to use data...medical officer of New York-based Antigenics. But, he said, "if we can replicate...study was in five patients. Now, Antigenics will be testing AG-858 in combination...

U.S. Patent Disclosures.
BIOWORLD Today; 11/4/2009; 814 words; Advanced Life Sciences Inc., of Woodridge, Ill., was awarded...derivatives thereof as antiviral agents. Antigenics Inc., of New York, was issued 15 U...infectious diseases. BioMarin Pharmaceutical Inc., of Novato, Calif., was issued...